Sanming Luyan Pharmaceutical Co., Ltd. announced that it will receive CNY 25,000,000 in an equity round of funding from returning investor Luyan Pharma Co.,Ltd. on October 27, 2021. Post closing, the registered capital of the company will increase from CNY 15,000,000 to CNY 40,000,000, and the investor will continue to hold 100% stake in the company. The transaction has been approved in the seventh meeting of the fifth board of directors of the investor, and is not subject to its shareholders' approval.